You just read:

Bird Rock Bio Receives Approval from ANVISA and CONEP to Initiate the First Phase 2 Study in Brazil of Gerilimzumab for Rheumatoid Arthritis

News provided by

Bird Rock Bio, Inc.

Jan 03, 2017, 08:00 ET